Baiyunshan "domestic Viagra" Jinge will also develop the traditional Chinese medicine "Viagra" for the first time

It is understood that ED is one of the four most common diseases in male reproductive system The incidence rate of ED in men over 40 years old is about 46%, incidence rate is about 127 million In the 1990s, Baiyunshan Jinge received the production approval from the State Food and Drug Administration and officially obtained the birth certificate At today's Baiyunshan Jinge press conference, detailed information such as the packaging of Jinge products was released for the first time The product is packaged in orange, green, pink and blue The tablets are pink and printed with Baiyunshan abbreviation "bys" Baiyunshan disclosed that Jinge will adopt different packaging specifications in different markets in the unit of 50mg / capsule, which can be divided into five packages: one package, two packages, three packages, four packages and ten packages According to Zhu Shaoxuan, director of Baiyunshan Pharmaceutical General Factory, as early as the 1990s, Baiyunshan Pharmaceutical General Factory began to research and develop sildenafil citrate raw materials and excipients, and applied for clinical approval according to the requirements of China's first-class new drugs for chemical drugs, and obtained the first-class new drug certificate for raw materials and tablets in 2003 Due to the application patent of Pfizer in China, Baiyunshan Pharmaceutical General Factory obtained approval Shan suspended the registration application of production approval documents It is understood that in the past decade, nearly 20 pharmaceutical companies have successively tried to copy Viagra In May this year, after the expiration of the "Viagra" patent, the reason why Baiyunshan Jinge won the first place was that the research and development started earlier Besides, there was the guidance of Friede Murad, the father of Viagra, who won the Nobel Prize in physiology and medicine According to Baiyunshan director of Guangyao, according to the consistency evaluation standard of the State Food and drug administration, Jinge has carried out comparative research on impurities, impurity spectrum, dissolution behavior, etc., which is consistent with "Viagra" Baiyunshan will also develop the traditional Chinese medicine "Viagra" by the end of October According to the 488 million male population aged 20-70 in China Statistical Yearbook 2013, the number of ED patients in China is 127 million With a 10% medical treatment rate, the number of ED patients exceeds 10 million and the market potential reaches 10 billion In the huge market, as the first "Viagra" national brand, the marketing strategy of Kingo has attracted much attention It is understood that more than 80% of the sales channels of ED drugs are in retail pharmacies Baiyunshan will sign cooperation agreements with several chain drugstores such as DASHENLIN and haiwangxingchen to open channels for the distribution of goods in Jinge Jinge will officially store the goods at the end of October this year Baiyunshan person in charge said that in terms of production capacity, the tablet workshop of Baiyunshan Pharmaceutical General Factory has a design capacity of 4 billion tablets / year, which can meet the market demand of Jinge; meanwhile, Baiyunshan chemical pharmaceutical factory under Baiyunshan branch of Guangzhou Pharmaceutical Co., Ltd also has the qualification to produce Jinge raw materials In 2004, the synthesis process of sildenafil citrate raw materials of Baiyunshan Pharmaceutical Co., Ltd "intermediates and preparation methods for preparation of camphorone" The invention patent was obtained In 2005, the preparation method of campylone was authorized These process patents have obvious advantages in the preparation method of raw materials In the view of the market, price will also become a major advantage of Jinge At present, three kinds of Viagra sold by foreign pharmaceutical companies in China sell for about 90 to 136 yuan each, which limits the purchasing power of some consumers Experts predict that due to self supply of raw materials, Baiyunshan Jinge will be expected to seize the market at a low price and achieve sales volume of 500 million to 1 billion yuan in the next three to five years, becoming a new profit growth point and large variety of Baiyunshan In addition, according to Li Chuyuan, chairman of Guangyao group, Baiyunshan will also develop a series of Viagra products, including the development of traditional Chinese medicine Viagra and other anti ed original research drugs, to form an anti ed drug product line